Nippon India Pharma Fund(G)

Scheme Returns

3.69%

Category Returns

3.05%

Riskometer

Low
Low to moderate
Moderate
Moderately High
High
Very High

NAV Chart

Trailing Returns

	1 Day	1 week	1 Mth	3 Mth	1 Yrs	3 Yrs	4 Yrs	5 Yrs	Since Inception
Nippon India Pharma Fund(G)	1.01	1.26	3.69	0.37	35.62	20.91	19.97	27.74	21.17
Equity - Sectoral Fund - Pharma & Health Care	-0.23	-1.18	3.05	-4.56	25.84	23.70	25.70	24.60	17.80

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

Scheme Profile

Portfolio Details

Divident Details

AMC

Nippon Life India Asset Management Limited

Fund

Nippon India Mutual Fund

Snapshot

Inception Date

05-Jun-2004
Initial Price

₹10
Entry Load

--
Size of Fund(in Cr.)

451,077.39
Scheme Plan

--
Scheme Class

Equity - Sectoral Fund - Pharma & Health Care
Objectives

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Scheme Type

Open ended scheme
Min. Investment

₹5,000
Exit Load

1
Latest NAV

512.9617
Fund Manager

Mr. Sailesh Raj Bhan
Fund Manager Profile

Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

Fund Information
AMC

Nippon Life India Asset Management Limited
Address

4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013
Phone

022-68087000
Fax

022-68087097
Email

customercare@nipponindiaim.in
Website

https://mf.nipponindiaim.com/

Registrar Agent
Registrar

KFin Technologies Limited
Address

Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032
Phone

(040) 23312454 23320751 23320752
Fax

(040) 23311968
Email

customercare@karvy.com
Website

https://mfs.kfintech.com/

Portfolio Details

Allocation

Equity : 96.93

Others : 3.07

Companies - Holding Percentage

Company	Market Value	hold percentage
Sun Pharmaceutical Industries Limited	116762.02	13.52
Divi's Laboratories Limited	83381.33	9.65
Lupin Limited	65699.39	7.61
Cipla Limited	47550.9	5.5
Apollo Hospitals Enterprise Limited	44305.56	5.13
Dr. Reddy's Laboratories Limited	44030.27	5.1
Vijaya Diagnostic Centre Limited	35294.64	4.09
Ajanta Pharma Limited	28996.02	3.36
MedPlus Health Services Limited	27900.75	3.23
Triparty Repo	27794.59	3.22
Gland Pharma Limited	26070	3.02
Abbott India Limited	23950.25	2.77
Mankind Pharma Limited	23026.11	2.67
JB Chemicals & Pharmaceuticals Limited	22191.26	2.57
Aurobindo Pharma Limited	21497.41	2.49
GlaxoSmithKline Pharmaceuticals Limited	20356.65	2.36
Zydus Lifesciences Limited	19325.1	2.24
Narayana Hrudayalaya Limited	19016	2.2
Thyrocare Technologies Limited	17664.56	2.04
Pfizer Limited	16909.36	1.96
Torrent Pharmaceuticals Limited	16732.83	1.94
Alkem Laboratories Limited	15652.83	1.81
Fortis Healthcare Limited	15161.6	1.76
Sanofi India Limited	14715.53	1.7
Syngene International Limited	10582.07	1.23
Orchid Pharma Limited	10444.82	1.21
Sanofi Consumer Healthcare India Limited	10309.9	1.19
Dr. Lal Path Labs Limited	8681.74	1.01
Indoco Remedies Limited	5958.92	0.69
Healthcare Global Enterprises Limited	4523.77	0.52
AstraZeneca Pharma India Limited	4206.21	0.49
Emcure Pharmaceuticals Limited	4095	0.47
IPCA Laboratories Limited	3676.07	0.43
Suraksha Diagnostic Limited	3500.05	0.41
Krishna Institute Of Medical Sciences Limited	2722.45	0.32
Concord Biotech Limited	2377.23	0.28
Cash Margin - CCIL	11.95	0
Net Current Assets	-1252	-0.14

Sectors - Holding Percentage

Sector	hold percentage
Healthcare	95.7%
Company Market Value Holding Sun Pharmaceutical Industries Limited 116762.02 13.52 Divi's Laboratories Limited 83381.33 9.65 Lupin Limited 65699.39 7.61 Cipla Limited 47550.9 5.5 Apollo Hospitals Enterprise Limited 44305.56 5.13 Dr. Reddy's Laboratories Limited 44030.27 5.1 Vijaya Diagnostic Centre Limited 35294.64 4.09 Ajanta Pharma Limited 28996.02 3.36 MedPlus Health Services Limited 27900.75 3.23 Gland Pharma Limited 26070 3.02 Abbott India Limited 23950.25 2.77 Mankind Pharma Limited 23026.11 2.67 JB Chemicals & Pharmaceuticals Limited 22191.26 2.57 Aurobindo Pharma Limited 21497.41 2.49 GlaxoSmithKline Pharmaceuticals Limited 20356.65 2.36 Zydus Lifesciences Limited 19325.1 2.24 Narayana Hrudayalaya Limited 19016 2.2 Thyrocare Technologies Limited 17664.56 2.04 Pfizer Limited 16909.36 1.96 Torrent Pharmaceuticals Limited 16732.83 1.94 Alkem Laboratories Limited 15652.83 1.81 Fortis Healthcare Limited 15161.6 1.76 Sanofi India Limited 14715.53 1.7 Orchid Pharma Limited 10444.82 1.21 Sanofi Consumer Healthcare India Limited 10309.9 1.19 Dr. Lal Path Labs Limited 8681.74 1.01 Indoco Remedies Limited 5958.92 0.69 Healthcare Global Enterprises Limited 4523.77 0.52 AstraZeneca Pharma India Limited 4206.21 0.49 Emcure Pharmaceuticals Limited 4095 0.47 IPCA Laboratories Limited 3676.07 0.43 Suraksha Diagnostic Limited 3500.05 0.41 Krishna Institute Of Medical Sciences Limited 2722.45 0.32 Concord Biotech Limited 2377.23 0.28
Miscellaneous	3.22%
Company Market Value Holding Triparty Repo 27794.59 3.22
Business Services	1.23%
Company Market Value Holding Syngene International Limited 10582.07 1.23

Divident Details

Scheme Name	Date	Dividend (%)
	No Data Found

Alternative Funds From Category

Scheme Name	Asset Size	1M	3M	6M	1Y	3Y
HDFC Pharma and Healthcare Fund - Growth Option	506.59	4.77	4.33	26.99	51.48	0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option	2552.23	4.33	1.56	21.85	47.49	25.74
LIC MF Healthcare Fund-Regular Plan-Growth	51.46	4.76	4.16	22.76	46.24	18.91
UTI Healthcare Fund - Regular Plan - Growth Option	5.42	4	1.67	22.81	44.5	22.23
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option	138.39	4.77	2.87	23.53	44	21.11
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH	7.7	4.15	3.08	20.38	42.39	25.29
DSP Healthcare Fund - Regular Plan - Growth	1243.08	2.05	1.91	23.28	41.56	23.06
Tata India Pharma & Healthcare Fund-Regular Plan-Growth	512.42	5.44	0.52	18.48	40.9	22.75
Mirae Asset Healthcare Fund -Regular Growth	1583.14	4.95	-0.14	18.93	40.13	19.84
Kotak Healthcare Fund - Regular Plan - Growth Option	214.38	5.92	2.48	21.15	40.12	0

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name	Asset Size	1M	3M	6M	1Y	3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option	62259.56	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	61646.36	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	61027.03	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	60999.55	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	60372.55	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	56468.75	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	51566.11	5.91	-0.56	6.23	30.72	28.82
Nippon India Small Cap Fund - Growth Plan - Growth Option	50422.78	5.91	-0.56	6.23	30.72	28.82
CPSE ETF	46793.08	-0.91	-9.74	-6.58	34.38	43.64
CPSE ETF	46098.89	-0.91	-9.74	-6.58	34.38	43.64